Mix Vaccine for Metastatic Kidney Cancer

Reaction - Mixed Vaccine Clinical Trial

Official title: Safety and Efficacy Study of Mix Vaccine in Kidney Cancer Patient

Status Completed

Clinical Trial Summary

The aim of this study is the safety and efficacy of mix vaccine to small metastases of kidney cancer.

Clinical Trial Description

By enrolling patients with small metastases of kidney cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of mix vaccine.

The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS). ;

Related Conditions & MeSH terms

• Carcinoma, Renal Cell
• Kidney Neoplasms
• Metastasis From Malignant Tumor of Kidney (Disorder)
• Neoplasms
• Reaction - Mixed Vaccine

• NCT number: NCT03357289
• Study type: Interventional
• Source: Fuda Cancer Hospital, Guangzhou
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: November 30, 2017
• Completion date: August 30, 2019